ARGAN, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 61.98 USD | +1.26% |
|
+0.10% | +32.46% |
| Apr. 24 | Argan: successful 150 ME capital increase | CF |
| Apr. 19 | Argan Insider Sold Shares Worth $899,850, According to a Recent SEC Filing | MT |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
Strengths
- The prospective high growth for the next fiscal years is among the main assets of the company
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
- For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Construction & Engineering
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| +32.46% | 821M | C | ||
| -2.29% | 67.67B | C+ | ||
| +2.13% | 59.37B | C+ | ||
| +21.25% | 38.3B | B+ | ||
| +11.23% | 30.73B | B | ||
| +2.06% | 26.35B | A- | ||
| +22.89% | 22.01B | B- | ||
| +15.06% | 19.47B | A | ||
| +22.99% | 17.6B | B+ | ||
| +64.33% | 16.64B | B |
Investor Rating
Trading Rating
-
ESG Refinitiv
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
-
Valuation
P/E ratio
EV / Sales
-
Price to Book
-
Price to Free Cash Flow
Yield
-
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-
Business Predictability
Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
Earnings quality
Environment
Emissions
Innovation
Use of resources
Governance
CSR Strategy
Management
Shareholders
Controversy
Controversy
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- AGX Stock
- Ratings Argan, Inc.
